Venous Thromboembolism Management Flashcards (94 cards)

All cards

1Question

What is venous thrombosis?

Answer

Partial or complete venous obstruction by an intraluminal thrombus formed when blood coagulates in a vein.

2Question

Which conditions comprise venous thromboembolic disease?

Answer

Deep vein thrombosis and pulmonary embolism.

3Question

What are the three components of Virchow’s triad, according to Rudolph Virchow?

Answer

Stasis, vessel-wall damage, and altered hemostasis.

4Question

What does venous stasis promote in the blood?

Answer

Accumulation of coagulation factors.

5Question

What does thrombin convert circulating fibrinogen into?

Answer

Insoluble fibrin.

6Question

Where do most fibrin-rich, red-cell-rich pulmonary emboli originate?

Answer

The deep veins of the lower limbs.

7Question

What does pulmonary vascular obstruction do to pulmonary artery pressure and right ventricular afterload?

Answer

It raises both.

8Question

What causes reduced left ventricular preload in pulmonary embolism?

Answer

Right ventricular compression of the left ventricle.

9Question

Where are proximal and distal DVTs located relative to the popliteal region?

Answer

Proximal DVT is above it; distal DVT is below it.

10Question

Why can clinical examination alone not establish DVT?

Answer

DVT signs are inconsistent and nonspecific, so both limbs should be compared.

11Question

What makes phlegmasia coerulea dolens a vascular emergency?

Answer

Severe venous obstruction and edema can compromise arterial flow in a cold, cyanotic limb with absent pulses.

12Question

When does superficial venous thrombosis carry greater embolic risk?

Answer

When the thrombus is extensive or near the great saphenous junction.

13Question

What must VTE etiological investigation never delay?

Answer

Anticoagulant treatment.

14Question

What treatment decision does VTE etiological investigation help determine?

Answer

Treatment duration.

15Question

How are VTE risk factors classified?

Answer

As transient provoking events or permanent patient-related factors.

16Question

How can multiple VTE risk factors act together?

Answer

They can coexist and interact additively.

17Question

Which categories of events are transient VTE risk factors?

Answer

Surgery, injuries, pregnancy-related events, and prolonged immobility or travel.

18Question

Which inherited thrombophilias are permanent risk factors for venous thromboembolism?

Answer

Antithrombin, protein S, or protein C deficiencies; activated protein C resistance or factor V Leiden; prothrombin gene 20210 mutation; and hyperhomocysteinemia.

19Question

Which acquired thrombophilias are permanent risk factors for venous thromboembolism?

Answer

Antiphospholipid syndrome and nephrotic syndrome.

20Question

Which other conditions and factors permanently increase venous thromboembolism risk?

Answer

Age, prior venous thromboembolism, active cancer or leukemia, myeloproliferative syndromes, chronic inflammatory diseases or infections, certain medications, cardiovascular disease, chronic venous insufficiency, venous compression, and obesity.

21Question

How do transient and permanent venous thromboembolism risk factors differ?

Answer

Transient factors are triggering events; permanent factors are patient-specific.

22Question

In what percentage of venous thrombosis cases can the etiological investigation remain negative, requiring surveillance?

Answer

30%.

23Question

How does MVTE risk change with each decade after age 40?

Answer

It doubles.

24Question

Which transient risk factors for MVTE can be investigated to help limit recurrence?

Answer

Prolonged sitting travel, prolonged bed rest, cast immobilization, recent surgery, pregnancy, and postpartum status.

25Question

How much does antithrombin deficiency increase thrombosis risk?

Answer

It increases the risk 10- to 50-fold.

26Question

How does activated protein C affect TCa in normal plasma?

Answer

It prolongs the TCa.

27Question

What determines short-term life-threatening prognosis in deep vein thrombosis?

Answer

The risks of pulmonary embolism or thrombus extension.

28Question

What is the major complication of venous thrombosis, and how should it be sought?

Answer

Pulmonary embolism; it should be sought systematically.

29Question

What does normal perfusion on pulmonary ventilation/perfusion scintigraphy exclude?

Answer

Pulmonary embolism.

30Question

Which findings are used to assess pulmonary embolism severity?

Answer

Hemodynamic instability, right-ventricular dysfunction, elevated troponins, and simplified PESI.

31Question

What conditions constitute hemodynamic instability in pulmonary embolism?

Answer

Cardiac arrest requiring resuscitation, obstructive shock, or persistent hypotension.

32Question

What defines obstructive shock in pulmonary embolism?

Answer

Low systolic pressure or vasopressor dependence despite fluids, together with organ injury from hypoperfusion.

33Question

What investigation is required for recurrent deep-vein thrombosis?

Answer

Investigation for an underlying cause.

34Question

What causes postphlebitic syndrome?

Answer

Destruction of venous valves and venous-wall damage from pre-thrombotic distension.

35Question

What is the aim of curative anticoagulant treatment for venous thrombosis?

Answer

To limit thrombus extension and reduce pulmonary embolism and early recurrence risks.

36Question

To what aPTT ratio is unfractionated heparin adjusted?

Answer

A patient-to-control ratio of 1.5–2.5.

37Question

What do anticoagulants do to thrombus extension and migration?

Answer

They prevent thrombus extension and migration.

38Question

When should fibrinolysis be used for pulmonary embolism with shock?

Answer

Unless an absolute contraindication is present.

39Question

How are anticoagulation duration decisions balanced using HERDOO2 and VTE-BLEED?

Answer

HERDOO2 assesses recurrence risk, while VTE-BLEED assesses bleeding risk.

40Question

What is the usual treatment of choice for proximal deep-vein thrombosis?

Answer

Direct oral anticoagulants.

41Question

How long is distal deep-vein thrombosis generally treated with anticoagulation?

Answer

3 months.

42Question

How is stable pulmonary embolism generally treated?

Answer

Like proximal deep-vein thrombosis.

43Question

How long is anticoagulation continued for cancer-associated venous thromboembolism?

Answer

While the cancer remains active and the treatment benefit-risk balance remains favorable.

44Question

What is the average annual incidence of venous thromboembolic disease?

Answer

Greater than 1 per 1,000 person-years.

45Question

How can venous thromboembolic disease threaten life in the short term?

Answer

Through pulmonary embolism.

46Question

What long-term condition can venous thromboembolic disease cause?

Answer

Post-thrombotic syndrome.

47Question

How can stasis promote venous thrombosis through endothelial injury?

Answer

It causes local hypoxia and endothelial injury, promoting platelet and leukocyte adhesion.

48Question

What do coagulation reactions generate from activated zymogens?

Answer

Thrombin, in enzymatic complexes containing calcium and phospholipids.

49Question

Which activated factors amplify thrombin generation?

Answer

Factors Va and VIIIa.

50Question

When are hemodynamic effects of pulmonary embolism observed?

Answer

When at least 50–60% of the pulmonary vascular bed is obstructed or emboli recur.

51Question

What ventilation–perfusion effect occurs initially in pulmonary embolism?

Answer

A dead-space effect in ventilated but unperfused regions.

52Question

What mainly causes hypoxemia in pulmonary embolism?

Answer

A shunt effect.

53Question

Where can DVT-related pain occur, and how may calf pain be triggered?

Answer

Pain may occur along a vein, in the calf, groin, or thigh; calf pain may be spontaneous or provoked by palpation or foot dorsiflexion.

54Question

What percentage of DVT cases show Homans’ sign, and how diagnostically reliable is it?

Answer

It is present in 60% of cases but has low sensitivity and specificity.

55Question

What edema and superficial venous changes can DVT cause?

Answer

DVT may cause firm, minimally pitting edema, local warmth, and superficial collateral venous dilation.

56Question

What commonly triggers upper-limb superficial venous thrombosis?

Answer

Venous catheter placement, intravenous contrast injection, or trauma.

57Question

How does upper-limb DVT typically progress anatomically?

Answer

Painful swelling starts on the back of the hand and progresses to the inner arm and axilla.

58Question

What is a common cause of upper-limb DVT?

Answer

Intravascular devices.

59Question

What determines which supplementary tests are chosen during etiological investigation?

Answer

The clinical presentation.

60Question

Which recent circumstances should the history assess in venous thromboembolism?

Answer

Travel, immobilization, surgery, trauma, pregnancy, or the postpartum period.

61Question

When are antinuclear antibodies, antiphospholipid tests, and inherited thrombophilia tests indicated?

Answer

According to context, especially by age 45 or with personal or family venous thromboembolism history.

62Question

Which conditions are risk factors for MVTE?

Answer

Prior venous thrombosis, obesity, venous insufficiency, and lower-limb varicose veins.

63Question

Which factors predict DVT in surgical patients?

Answer

Age over 40, bed rest over five days, prior MVTE, orthopedic surgery, and cancer surgery.

64Question

How are inherited antithrombin, protein C, and protein S deficiencies transmitted?

Answer

They are transmitted in an autosomal dominant manner.

65Question

When should antithrombin and protein C and S levels be measured relative to anticoagulants?

Answer

Measure antithrombin before heparin and proteins C and S before vitamin K antagonists.

66Question

What can protein C deficiency cause when vitamin K antagonist treatment begins?

Answer

It can cause cutaneous necrosis.

67Question

What can cause thrombus extension despite anticoagulation?

Answer

Underdosing or heparin resistance, including from antithrombin deficiency or heparin-induced thrombocytopenia.

68Question

Where can a distal deep vein thrombosis extend?

Answer

Into the proximal venous territory.

69Question

What should be investigated when thrombosis extends despite effective-dose anticoagulation?

Answer

An underlying cause, such as cancer.

70Question

How does associated pulmonary disease affect ventilation/perfusion scintigraphy results?

Answer

It makes results much more often indeterminate.

71Question

When is ventilation/perfusion scintigraphy used instead of CT pulmonary angiography?

Answer

When CT pulmonary angiography is contraindicated or according to hospital availability.

72Question

What can transthoracic echocardiography rarely show directly in pulmonary embolism?

Answer

A thrombus in the pulmonary artery.

73Question

What can echocardiography assess in cardiogenic shock?

Answer

Left-ventricular impact, including markedly reduced cardiac output and cardiac index.

74Question

What defines persistent hypotension in pulmonary embolism?

Answer

Systolic pressure below 90 mmHg or a fall of at least 40 mmHg lasting over 15 minutes, without specified alternative causes.

75Question

Which imaging findings indicate right-ventricular dysfunction in pulmonary embolism?

Answer

Echocardiography shows right-ventricular dilation, systolic dysfunction, or pulmonary hypertension; CT shows right-ventricular dilation.

76Question

Which factors are considered when assessing venous thromboembolism recurrence?

Answer

Sex, provocation status, pulmonary-embolism mortality risk, persistence of an underlying cause, age, BMI, follow-up D-dimer levels, and postphlebitic signs.

77Question

Which score uses age, BMI, follow-up D-dimer, and postphlebitic signs to assess recurrence risk in women after anticoagulant cessation?

Answer

The HERDOO2 score.

78Question

What is the most feared complication of postphlebitic syndrome?

Answer

A venous leg ulcer.

79Question

What must be obtained and excluded before starting heparin?

Answer

Blood group, creatinine and calculated clearance, blood count with platelets, PT, aPTT, and anticoagulation contraindications.

80Question

Which platelet count is an absolute contraindication to anticoagulation?

Answer

A count below 50,000 G/L.

81Question

What is the usual initial intravenous unfractionated-heparin bolus?

Answer

100 IU/kg.

82Question

How does fibrinolysis compare with unfractionated heparin alone in restoring pulmonary perfusion?

Answer

It restores pulmonary perfusion faster.

83Question

What is the accelerated streptokinase regimen for thrombolysis?

Answer

1,500,000 IU over 2 hours.

84Question

What is the maximum alteplase dose in the 15-minute regimen?

Answer

50 mg.

85Question

How many VTE-BLEED points are assigned for active cancer?

Answer

2 points.

86Question

Has direct oral anticoagulant superiority been established for superficial venous thrombosis?

Answer

No superiority has been established.

87Question

When is unfractionated heparin followed by a vitamin K antagonist reserved for pulmonary embolism?

Answer

For severe or unstable pulmonary embolism, severe renal impairment, or particular bleeding risk.

88Question

Which patients classically receive low-molecular-weight heparin without vitamin K antagonist relay?

Answer

Patients with cancer-associated pulmonary embolism or pregnancy.

89Question

How long is pulmonary embolism provoked by surgery or limb trauma treated?

Answer

For 3 months.

90Question

What are the symptom and risk effects of elastic compression in deep-vein thrombosis?

Answer

It rapidly improves symptoms and limits post-thrombotic disease risk.

91Question

How is compression worn during the first days and afterward?

Answer

Continuously during the first days, then during the daytime.

92Question

What role does bed rest have in venous thromboembolism treatment?

Answer

Bed rest has no role, particularly after anticoagulation begins.

93Question

When is an inferior vena cava filter mainly indicated?

Answer

When anticoagulation fails or is contraindicated.

94Question

In which condition is venous thrombectomy mandatory?

Answer

Phlegmasia cerulea dolens.

Test yourself with the quiz

Answer 56 questions on Venous Thromboembolism Management.

1. A clot formed inside a vein partially obstructs its lumen. What is this condition called?

2. A patient has a deep vein clot that has led to obstruction of a pulmonary artery by a traveling thrombus. Which condition pair describes this venous thromboembolic disease?

Take the quiz →

Read the study guide

Go over the full study guide for Venous Thromboembolism Management.

Read the study guide →

Related classes

Make your own flashcards

Upload your class notes and Revizly writes your flashcards in about a minute.

Flashcard maker